Boardroom Alpha
Boardroom Alpha
CLYM · Additional Proxy Materials (DEFA14A) · Filed April 24, 2026

Climb Bio Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
April 24, 2026
Ticker
CLYM
Accession
0001193125-26-177302
Boardroom Alpha · Filing insights

Climb Bio's board urges support for its nominees and key proposals at the June 5, 2026 meeting.

About Climb Bio Inc
Market cap
$641M
1Y TSR
+774.2%
3Y TSR
+56.8%
Board grade
C+
Sector
Healthcare
CEO
Aoife Brennan
Last annual meeting: Jun 5, 2026 · View full Climb Bio Inc profile →
DEFA14A
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

 

 

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material under § 240.14a-12

 

 

Climb Bio, Inc.

(Name of Registrant as Specified In Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

 

No fee required

 

Fee paid previously with preliminary materials

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 
 

 


 

LOGO

 

PROXY TABULATOR P.O. BOX 8016, CARY, NC 27512-9903

 

LOGO

   LOGO

 

 

 

Climb Bio, Inc.

 

Annual Meeting of Stockholders

 

Friday, June 5, 2026 9:00 AM, Eastern Time

 

Annual Meeting to be held exclusively via the Internet - please visit www.proxydocs.com/CLYM for more details.

 

You must register to attend the meeting online and/or participate at www.proxydocs.com/CLYM

 

 

For a convenient way to view proxy materials, VOTE, and obtain directions to attend the meeting go to www.proxydocs.com/CLYM

 

To vote your proxy while visiting this site, you will need the 12 digit control number in the box below.

 

This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the Internet.

 

If you want to receive a paper or email copy of the proxy materials, you must request one on or before May 25, 2026. There is no charge to you for requesting a copy. Unless requested, you will not otherwise receive a paper or email copy.

     

 

Proxy Materials: Notice of Meeting and Proxy Statement & Annual Report on Form 10-K

 

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders To Be Held on June 5, 2026 For Stockholders of Record as of April 7, 2026.

 

To request paper copies of the proxy materials, use one of the following methods.

 

LOGO

 

Internet:

www.investorelections.com/CLYM

 

LOGO

 

Call:

1-866-648-8133

 

LOGO

 

Email:

paper@investorelections.com

 

* If requesting a copy of the proxy materials by email, please send a blank email with the 12 digit control number (located below) in the subject line. No other requests, instructions OR other inquiries should be included with your email requesting a copy of the proxy materials.

 

     

 

LOGO

 
   

Have the 12 digit control number located in the box above available when you access the website and follow the instructions.

 

SEE REVERSE FOR FULL AGENDA    

Copyright © 2026 BetaNXT, Inc. or its affiliates. All Rights Reserved


LOGO    Climb Bio, Inc. Annual Meeting of Stockholders

THE BOARD OF DIRECTORS RECOMMENDS A VOTE:

FOR EACH OF THE NOMINEES IN PROPOSAL 1 AND

FOR PROPOSAL 2, PROPOSAL 3 AND PROPOSAL 4.

 

    

 

PROPOSAL

 

1.    The election of two Class II directors, each to serve for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until his respective successor has been duly elected and qualified;
   1.01 Alexander (Bo) Cumbo
   1.02 Douglas Williams, Ph.D.
2.    The ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;
3.    The approval of an amendment to our Amended and Restated Certificate of Incorporation, as amended, relating to the removal of directors for “cause”;
4.    The approval of an amendment to our 2021 Equity Incentive Plan to amend the provision providing for an automatic share pool increase to include prefunded warrants in the calculation of the annual increase; and
5.    The transaction of any other business that may properly come before the 2026 Annual Meeting or any adjournment or postponement thereof.
From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Climb Bio Inc (CLYM)

Reference

Frequently asked questions

When did Climb Bio Inc file this DEFA14A?
Climb Bio Inc (CLYM) filed this Additional Proxy Materials (DEFA14A) with the SEC on April 24, 2026. The accession number assigned by EDGAR is 0001193125-26-177302.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Climb Bio's board urges support for its nominees and key proposals at the June 5, 2026 meeting. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Climb Bio Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Climb Bio Inc has filed under CIK 1768446, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer